Todas as matérias desta seção, das mais recentes às mais antigas — página 240 de 371.
Satellos Bioscience (NASDAQ:MSLE), a biotechnology company focused on developing small-molecule therapies that modulate muscle stem cell regeneration, reported its full-year 2025 financial results and provided updates on recent corporate and clinical milestones.
Humacyte (NASDAQ:HUMA), a pioneer in universally implantable, bioengineered human tissues, today announced its financial results for the fourth quarter and full year ended December 31, 2025.
Autolus Therapeutics (NASDAQ:AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today reported its financial results for the fourth quarter and full year ended December 31, 2025.
Super League (NASDAQ:SLE), a creator and publisher of content experiences and media solutions across the world’s largest immersive platforms, today reported record-breaking financial results for the fourth quarter and full year ended December 31, 2025.
51Talk Online Education Group (NYSE:COE), a leading global online English education platform, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025.
LM Funding America (NASDAQ:LMFA), a cryptocurrency mining and specialty finance company, today announced its financial results for the fourth quarter and full year ended December 31, 2025.
BioXcel Therapeutics (NASDAQ:BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today reported its financial results for the fourth quarter and full year ended December 31, 2025.
Instil Bio (NASDAQ:TIL), a clinical-stage biopharmaceutical company, today reported its financial results for the fourth quarter and full year ended December 31, 2025, while outlining a transformative shift in its corporate strategy.
AstraZeneca (NASDAQ:AZN) today announced positive high-level results from the OBERON and TITANIA Phase III trials, marking a historic milestone in the treatment of chronic obstructive pulmonary disease (COPD).
Legence (NASDAQ:LGN), a preeminent integrated provider of energy efficiency and sustainability solutions for the built environment, today reported record-breaking financial results for the fourth quarter and full year ended December 31, 2025.
SBC Medical Group Holdings (NASDAQ:SBC), a leading Management Services Organization (MSO) for a diverse range of medical franchises, today announced its financial results for the fourth quarter and full fiscal year ended December 31, 2025.
Novo Nordisk (NYSE:NVO) today announced that the U.S. Food and Drug Administration (FDA) has approved Awiqli® (insulin icodec-abae), the first and only once-weekly, long-acting basal insulin for adults living with type 2 diabetes.
Gravity (NASDAQ:GRVY), a developer and publisher of online and mobile games, today announced its consolidated financial results for the fiscal year ended December 31, 2025.
Kopin (NASDAQ:KOPN), a developer of application-specific optical systems and high-performance microdisplays, today announced preliminary unaudited financial results for the fourth quarter ended December 27, 2025.
Yunji (NASDAQ:YJ), a leading membership-based social e-commerce platform in China, today announced its unaudited financial results for the second half and fiscal year ended December 31, 2025.
Huize Holding (NASDAQ:HUIZ), a leading digital insurance product and service platform in China, today announced record-breaking financial and operational results for the full year ended December 31, 2025.
Boqii Holding (NYSE:BQ), a long-term destination for pet lovers in China, today reported its unaudited financial results for the six months ended September 30, 2025.
Pharming Group (NASDAQ:PHAR), a global biopharmaceutical company dedicated to transforming the lives of patients with rare diseases, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion.
Netflix (NASDAQ:NFLX) shares climbed 1.1% to $93.32 on Thursday, providing a much-needed lift for the stock following a period of underperformance.
Shares of Meta Platforms (NASDAQ:META) fell more than 8% on Thursday following a landmark Los Angeles jury verdict that found the company, alongside Google parent Alphabet (NASDAQ:GOOGL) negligent in protecting young users from addictive platform designs.
Lucid Diagnostics (NASDAQ:LUCD), a commercial-stage medical diagnostics company focused on the early detection of esophageal precancer, today reported financial and operational results for the fourth quarter and full year ended December 31, 2025.
GigaMedia (NASDAQ:GIGM), a major provider of online games and cloud computing services, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025.
Sypris Solutions (NASDAQ:SYPR), a diversified provider of outsourced services and specialty products, today reported financial results for its fourth quarter and full year ended December 31, 2025.
BRP (NASDAQ:DOOO), the global leader in powersports vehicles and propulsion systems, today announced its financial results for the fourth quarter and full fiscal year ended January 31, 2026.
